Scott Koenig - 08 Feb 2026 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
08 Feb 2026
Net transactions value
$0
Form type
4
Filing time
10 Feb 2026, 18:17:18 UTC
Previous filing
15 Aug 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Koenig Scott Director 9704 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Beth A. Smith, Attorney-in-fact 10 Feb 2026 0001587514

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise +15,831 +1.9% 846,075 08 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -15,831 -50% $0.000000 15,832 08 Feb 2026 Common Stock 15,831 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into the Company's stock on a one-for-one basis.
F2 On February 8, 2024, the reporting person was granted 95,000 restricted stock units. One-third of the restricted stock units vested after one year and one-half of the remaining units vested pursuant to the reporting person's "Separation Agreement" on August 13, 2025. The remaining units vest in two equal installments on the anniversary of the grant date.